Literature DB >> 17379546

The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles.

Kathryn A Pape1, Drew M Catron, Andrea A Itano, Marc K Jenkins.   

Abstract

The initial step in a humoral immune response involves the acquisition of antigens by B cells via surface immunoglobulin. Surprisingly, anatomic studies indicate that lymph-borne proteins do not have access to the follicles where naive B cells reside. Thus, it is unclear how B cells acquire antigens that drain to lymph nodes. By tracking a fluorescent antigen and a peptide:MHC II complex derived from it, we show that antigen-specific B cells residing in the follicles acquire antigen within minutes of injection, first in the region closest to the subcapsular sinus where lymph enters the lymph node. Antigen acquisition, presentation, and subsequent T cell-dependent activation did not require B cell migration through the T cell area or exposure to dendritic cells. These results indicate that the humoral response is initiated as soluble antigens diffuse directly from lymph in the subcapsular sinus to be acquired by antigen-specific B cells in the underlying follicles.

Mesh:

Substances:

Year:  2007        PMID: 17379546     DOI: 10.1016/j.immuni.2007.02.011

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  155 in total

1.  Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis.

Authors:  Simona Schlereth; Hyun Soo Lee; Payal Khandelwal; Daniel R Saban
Journal:  Am J Pathol       Date:  2012-04-14       Impact factor: 4.307

2.  Preferential localization of IgG memory B cells adjacent to contracted germinal centers.

Authors:  Yuichi Aiba; Kohei Kometani; Megumi Hamadate; Saya Moriyama; Asako Sakaue-Sawano; Michio Tomura; Hervé Luche; Hans Jörg Fehling; Rafael Casellas; Osami Kanagawa; Atsushi Miyawaki; Tomohiro Kurosaki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

Review 3.  B cell follicles and antigen encounters of the third kind.

Authors:  Jason G Cyster
Journal:  Nat Immunol       Date:  2010-10-19       Impact factor: 25.606

Review 4.  From optical bench to cageside: intravital microscopy on the long road to rational vaccine design.

Authors:  Heather D Hickman; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 5.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 6.  Complement-dependent transport of antigen into B cell follicles.

Authors:  Santiago F Gonzalez; Veronika Lukacs-Kornek; Michael P Kuligowski; Lisa A Pitcher; Søren E Degn; Shannon J Turley; Michael C Carroll
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

Review 7.  CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity.

Authors:  G Elizabeth Pluhar; Christopher A Pennell; Michael R Olin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

8.  Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes.

Authors:  Rafael Cubas; Sheng Zhang; Sunkuk Kwon; Eva M Sevick-Muraca; Min Li; Changyi Chen; Qizhi Yao
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

9.  Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation.

Authors:  Deepta Bhattacharya; Ming T Cheah; Christopher B Franco; Naoki Hosen; Christopher L Pin; William C Sha; Irving L Weissman
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

10.  Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses.

Authors:  Michael Y Gerner; Kerry A Casey; Matthew F Mescher
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.